BRCA1 and ovarian cancer: Muhammad et al. discovered BRCA1/2 variants in pancreatic cancer patients, suggesting the greater significance of BRCA mutations beyond breast cancer [33], whereas Rashid et al. observed recurrent and founder BRCA1 alterations among families with breast and ovarian cancer [34].